The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease

Background: The mechanisms of Parkinson's disease (PD) include complicated genetic factors. The roles of newly found risk genes need to be further verified among different ethnicities. In a two-stage meta-analysis, single nucleotide polymorphism (SNP) of rs156429 in glycoprotein non-metastatic...

Full description

Bibliographic Details
Main Authors: Jin Liu, Gen Li, Yixi He, Guiying He, Pingchen Zhang, Xin Shen, Weishan Zhang, Shengdi Chen, Shishuang Cui, Yuyan Tan
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2020.00952/full
_version_ 1819141387786911744
author Jin Liu
Gen Li
Yixi He
Guiying He
Pingchen Zhang
Xin Shen
Weishan Zhang
Shengdi Chen
Shishuang Cui
Yuyan Tan
author_facet Jin Liu
Gen Li
Yixi He
Guiying He
Pingchen Zhang
Xin Shen
Weishan Zhang
Shengdi Chen
Shishuang Cui
Yuyan Tan
author_sort Jin Liu
collection DOAJ
description Background: The mechanisms of Parkinson's disease (PD) include complicated genetic factors. The roles of newly found risk genes need to be further verified among different ethnicities. In a two-stage meta-analysis, single nucleotide polymorphism (SNP) of rs156429 in glycoprotein non-metastatic melanoma protein B (GPNMB) was reported to be associated with PD. So far clinical studies have focused on association between rs156429 and PD onset, however there is little evidence linking rs156429 with PD symptoms.Objective: This study aimed to investigate the possible association of GPNMB rs156429 with PD manifestations among southeastern Chinese people.Methods: Demographic variables, disease-related factors, and motor and non-motor assessments of 511 PD patients were collected. Polymerase chain reaction (PCR) and SNaPshot technique were used to detect GPNMB rs156429. The associations of rs156429 with PD rating scales and clinical manifestations were analyzed by Kruskal-Wallis test and logistic regression model separately.Results: Kruskal-Wallis test and logistic regression model failed to reveal an association between GPNMB rs156429 and scores from Montreal Cognitive Assessment (MoCA) (p = 0.037; p = 1.000 after correction), and pain symptoms of 511 PD patients (p = 0.008, OR = 0.59, 95% CI = 0.40–0.87, overdominant model after adjustment; p = 0.168 after correction, overdominant model after adjustment). However, further analysis based on genders showed that GPNMB rs156429 might have a trend for being associated with cognitive dysfunction (Mini-Mental State Examination (MMSE), p = 0.064 after correction; MoCA, p = 0.064 after correction) and pain symptoms (p = 0.063 after correction, overdominant model after adjustment) in female PD patients but not male patients.Conclusions: This study revealed that GPNMB rs156429 might have a trend for being associated with cognitive dysfunction and pain symptoms of female PD patients in the southeastern Chinese population. Further studies from a larger sample size are needed to confirm these findings.
first_indexed 2024-12-22T11:53:39Z
format Article
id doaj.art-ae757976932a40a6baee275ad8757f32
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-12-22T11:53:39Z
publishDate 2020-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-ae757976932a40a6baee275ad8757f322022-12-21T18:26:55ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-09-011110.3389/fgene.2020.00952540334The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's DiseaseJin Liu0Gen Li1Yixi He2Guiying He3Pingchen Zhang4Xin Shen5Weishan Zhang6Shengdi Chen7Shishuang Cui8Yuyan Tan9Department of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Geriatrics, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Neurology & Collaborative Innovation Center for Brain Science, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaBackground: The mechanisms of Parkinson's disease (PD) include complicated genetic factors. The roles of newly found risk genes need to be further verified among different ethnicities. In a two-stage meta-analysis, single nucleotide polymorphism (SNP) of rs156429 in glycoprotein non-metastatic melanoma protein B (GPNMB) was reported to be associated with PD. So far clinical studies have focused on association between rs156429 and PD onset, however there is little evidence linking rs156429 with PD symptoms.Objective: This study aimed to investigate the possible association of GPNMB rs156429 with PD manifestations among southeastern Chinese people.Methods: Demographic variables, disease-related factors, and motor and non-motor assessments of 511 PD patients were collected. Polymerase chain reaction (PCR) and SNaPshot technique were used to detect GPNMB rs156429. The associations of rs156429 with PD rating scales and clinical manifestations were analyzed by Kruskal-Wallis test and logistic regression model separately.Results: Kruskal-Wallis test and logistic regression model failed to reveal an association between GPNMB rs156429 and scores from Montreal Cognitive Assessment (MoCA) (p = 0.037; p = 1.000 after correction), and pain symptoms of 511 PD patients (p = 0.008, OR = 0.59, 95% CI = 0.40–0.87, overdominant model after adjustment; p = 0.168 after correction, overdominant model after adjustment). However, further analysis based on genders showed that GPNMB rs156429 might have a trend for being associated with cognitive dysfunction (Mini-Mental State Examination (MMSE), p = 0.064 after correction; MoCA, p = 0.064 after correction) and pain symptoms (p = 0.063 after correction, overdominant model after adjustment) in female PD patients but not male patients.Conclusions: This study revealed that GPNMB rs156429 might have a trend for being associated with cognitive dysfunction and pain symptoms of female PD patients in the southeastern Chinese population. Further studies from a larger sample size are needed to confirm these findings.https://www.frontiersin.org/article/10.3389/fgene.2020.00952/fullParkinson's diseasesingle nucleotide polymorphismsGPNMBgeneticsclinical manifestation
spellingShingle Jin Liu
Gen Li
Yixi He
Guiying He
Pingchen Zhang
Xin Shen
Weishan Zhang
Shengdi Chen
Shishuang Cui
Yuyan Tan
The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease
Frontiers in Genetics
Parkinson's disease
single nucleotide polymorphisms
GPNMB
genetics
clinical manifestation
title The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease
title_full The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease
title_fullStr The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease
title_full_unstemmed The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease
title_short The Association Analysis of GPNMB rs156429 With Clinical Manifestations in Chinese Population With Parkinson's Disease
title_sort association analysis of gpnmb rs156429 with clinical manifestations in chinese population with parkinson s disease
topic Parkinson's disease
single nucleotide polymorphisms
GPNMB
genetics
clinical manifestation
url https://www.frontiersin.org/article/10.3389/fgene.2020.00952/full
work_keys_str_mv AT jinliu theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT genli theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT yixihe theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT guiyinghe theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT pingchenzhang theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT xinshen theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT weishanzhang theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT shengdichen theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT shishuangcui theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT yuyantan theassociationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT jinliu associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT genli associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT yixihe associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT guiyinghe associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT pingchenzhang associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT xinshen associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT weishanzhang associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT shengdichen associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT shishuangcui associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease
AT yuyantan associationanalysisofgpnmbrs156429withclinicalmanifestationsinchinesepopulationwithparkinsonsdisease